Cargando…

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis

OBJECTIVES: To evaluate the clinical outcomes of gonadotropin-releasing hormone analog (GnRHa) combined with implantation of a levonorgestrel-releasing intrauterine system (LNG-IUS) in adenomyosis patients with significantly enlarged uteruses. SUBJECTS AND METHODS: Twenty-one adenomyosis patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peihai, Song, Kun, Li, Li, Yukuwa, Kazunori, Kong, Beihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2013
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586783/ https://www.ncbi.nlm.nih.gov/pubmed/23796720 http://dx.doi.org/10.1159/000351431

Ejemplares similares

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Retracted: Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2022)

Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study
por: Chen, Shuyi, et al.
Publicado: (2020)

Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis
por: Cai, Yuru, et al.
Publicado: (2023)

An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
por: Zhang, Huizhi, et al.
Publicado: (2022)

Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)

The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report
por: Cui, HaiHong, et al.
Publicado: (2023)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

The Effects of Gonadotropin-Releasing Hormone Analog and a Combination of Gonadotropin-Releasing Hormone Analog and Recombinant Human Growth Hormone on Adult Height in Girls with Early Puberty
por: Hajzadeh, Ghodsieh, et al.
Publicado: (2019)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
por: Kumar, Pratap, et al.
Publicado: (2014)

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
por: Huerta-Reyes, Maira, et al.
Publicado: (2019)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022)

Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training
por: Huang, JinCheng, et al.
Publicado: (2023)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016)

Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Long-term efficacy and safety of levonorgestrel-releasing intrauterine system as a maintenance treatment for endometriosis
por: Kim, Hye Yun, et al.
Publicado: (2022)

Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia
por: Chen, Junyu, et al.
Publicado: (2022)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022)

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners
por: Nanda, Geeta, et al.
Publicado: (2018)

Effects of the levonorgestrel‐releasing intrauterine device on the immune microenvironment of the human cervix and endometrium
por: Shanmugasundaram, Uma, et al.
Publicado: (2016)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

Efficacy of levonorgestrel releasing intrauterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women
por: Desai, Rathnamala M.
Publicado: (2012)

Experience and levels of satisfaction with the levonorgestrel-releasing intrauterine system in China: a prospective multicenter survey
por: Zhao, Shuping, et al.
Publicado: (2014)

Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users
por: Spotnitz, Matthew E., et al.
Publicado: (2020)

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)

Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system
por: Steshenko, Alexander, et al.
Publicado: (2021)

An Interesting Image of Transmural Migration of a Levonorgestrel-Releasing Intrauterine Device (LNg-IUD)
por: Mitranovici, Melinda-Ildiko, et al.
Publicado: (2022)

Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review
por: Zürcher, Aline, et al.
Publicado: (2022)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5jojn0g5onal2bar3d1he0shkb